Evidence Continues to Indicate Fish Oil Omega-3 Fats Protect Against Heart Disease and Promote Wellness
The findings of the recent “ORIGIN” study should not be misinterpreted, warns Richard Passwater, Ph.D., Research Director of the Selenium Nutritional Research Center in Berlin, MD.
Berlin, MD (PRWEB) August 09, 2012
The findings of the recent “ORIGIN” study should not be misinterpreted, warns Richard Passwater, Ph.D., Research Director of the Selenium Nutritional Research Center in Berlin, MD. “The typical American diet provides insufficient fish, fish oils and related foods to provide desired levels of the omega-3 fatty acids EPA and DHA for optimal health, states Passwater, who is also the co-author of the new book, “The Missing Wellness Factors—EPA and DHA.” (Basic Health Publications, Inc., Laguna Beach, CA.) (http://www.drpasswater.com/images/WellnessFactors.jpg) (1)
“It is important that people are not misled by the “ORIGIN” omega-3 study published in the July 26 New England Journal of Medicine, Passwater emphasizes. (http://www.nejm.org/doi/full/10.1056/NEJMoa1203859?query=TOC ) (2), Passwater, points out that “the design limitations of the “ORIGIN” study would mask positive contributions of the omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Passwater notes that there is a compelling body of science that establishes that insufficient levels of the omega-3 fatty acids, EPA and DHA, in American diets precludes optimal health and contributes to 72,000 – 96,000 deaths per year. The “ORIGIN” study does not negate the total body of science due to its several design limitations.”
Passwater and Professor Jørn Dyerberg, MD, DMSc., University of Copenhagen, have distilled the immense body of science regarding fish, fish oils and related omega-3 foods involving approximately 20,000 studies developed over more than 40 years into their new book, “The Missing Wellness Factors – EPA and DHA.” Dyerberg is the world’s groundbreaking researcher in fish oils and the omega-3 fatty acids, EPA and DHA.
The “ORIGIN” study involved patients with dysglycemia who were prescribed statins, antithrombotics and antihypertensive medications. “Even if no design limitations existed,” Passwater notes, “a study of patients having prolonged biochemical disorders exacerbated by an inadequacy of EPA and DHA merely shows that a short drug-like treatment is insufficient to undo the damage established over decades and does not negate the fact that a lifelong pattern of adequate intake of EPA and DHA in a healthy population reduces the risk of disease.” Passwater adds, “The amount of EPA used in the recent study was inadequate to overcome the masking effect of the medications and given for too short of a duration. In addition, omega-3 Index measurements would be needed to establish baseline values to determine if EPA and DHA values were insufficient or already optimized.”
Passwater and Dyerberg discuss 56 studies in their chapter on cardiovascular disease in their new book, as well as hundreds more studies in their chapters on stroke, memory, cognition, Alzheimer’s disease and other dementias, depression, bipolar disorders, schizophrenia, aging, arthritis, diabetes and cancer.
Dyerberg and Passwater convincingly make the case that the omega-3 fatty acids EPA and DHA are essential for optimal health and well-being. Additionala information is available from the publisher, Basic Health Publications, Inc. (http://www.basichealthpub.com/detail.php?ProductID=268)
1. The Missing Wellness Factors – EPA and DHA. Dyerberg, J. and Passwater, R. ISBN 978-1-59120-300-1 Basic Health Publications, Inc. Laguna Beach, CA. (2012).
2. n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia. The ORIGIN Trial Investigators. N Engl J Med 2012; 367:309-318July 26, 2012.